PMID: 8952744Jan 1, 1996Paper

Prolactin and systemic lupus erythematosus

Annales de médecine interne
R W McMurray

Abstract

Prolactin in a pituitary peptide hormone which is immunomodulatory. Increased serum prolactin concentrations accelerate autoimmunity in the NZB x NZW F1 mouse model of SLE. Some patients with SLE are hyperprolactinemic and, in cross-sectional and longitudinal studies, serum prolactin has been associated with or correlated to lupus disease activity. Suppression of physiologic levels of prolactin by bromocriptine administration was associated with improvement in SLE in a preliminary study. While specific mechanisms remain to be elucidated, prolactin appears to be immunostimulatory in patients with SLE. A better understanding of its role and its interactions with other immunoregulatory hormones in SLE may lead to novel therapies for the suppression of this hormonally sensitive autoimmune disease.

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.